RxDoctor Payments Data

Jaime Nix

Nurse Practitioner · Odessa, TXNPI 1154098846

Payments from drug & device makers

$4,266in general payments, 2019–2025

Across 238 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$450
  • Amgen$394
  • AbbVie$375
  • AstraZeneca$349
  • Lilly USA, LLC$265
  • Axsome Therapeutics, Inc.$256
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$4,15697%
  • Education$1103%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,266 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide16$17,814
MounjaroTirzepatide12$15,893
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$6,389
Roflumilast12$722
Olmesartan Medoxomil43$493
Duloxetine Hcl18$430
Montelukast Sodium27$255
Amlodipine Besylate39$241
Atorvastatin Calcium33$239
Levothyroxine Sodium24$229
Pantoprazole Sodium21$185
Celecoxib11$165
Carvedilol32$141
Tizanidine Hcl12$127
Methylprednisolone14$99

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$450$17,81416 claims
Lilly USA, LLCMounjaro$265$15,89312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,422 nurse practitioner providers in Texas.

Other nurse practitioner in Odessa

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →